Author
Listed:
- Sandra Misale
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy
University of Torino Medical School, 10060 Candiolo (Torino), Italy)
- Rona Yaeger
(Memorial Sloan-Kettering Cancer Center)
- Sebastijan Hobor
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy)
- Elisa Scala
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy
University of Torino Medical School, 10060 Candiolo (Torino), Italy)
- Manickam Janakiraman
(Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center)
- David Liska
(Memorial Sloan-Kettering Cancer Center)
- Emanuele Valtorta
(Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy)
- Roberta Schiavo
(Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy)
- Michela Buscarino
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy
University of Torino Medical School, 10060 Candiolo (Torino), Italy)
- Giulia Siravegna
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy)
- Katia Bencardino
(Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy)
- Andrea Cercek
(Memorial Sloan-Kettering Cancer Center)
- Chin-Tung Chen
(Memorial Sloan-Kettering Cancer Center)
- Silvio Veronese
(Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy)
- Carlo Zanon
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy)
- Andrea Sartore-Bianchi
(Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy)
- Marcello Gambacorta
(Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy)
- Margherita Gallicchio
(University of Torino, 10125 Torino, Italy)
- Efsevia Vakiani
(Memorial Sloan-Kettering Cancer Center)
- Valentina Boscaro
(University of Torino, 10125 Torino, Italy)
- Enzo Medico
(University of Torino Medical School, 10060 Candiolo (Torino), Italy
Laboratory of Functional Genomics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy)
- Martin Weiser
(Memorial Sloan-Kettering Cancer Center)
- Salvatore Siena
(Ospedale Niguarda Ca’ Granda, 20162 Milano, Italy)
- Federica Di Nicolantonio
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy
FIRC Institute of Molecular Oncology (IFOM), 20139 Milano, Italy)
- David Solit
(Memorial Sloan-Kettering Cancer Center
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center)
- Alberto Bardelli
(Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment (IRCC), 10060 Candiolo (Torino), Italy
University of Torino Medical School, 10060 Candiolo (Torino), Italy
FIRC Institute of Molecular Oncology (IFOM), 20139 Milano, Italy)
Abstract
Molecular alterations in KRAS are associated with acquired resistance to anti-epidermal growth factor receptor (EGFR) treatment in colorectal cancer; resistant mutations can be identified in the blood of patients, months before clinical evidence of disease progression.
Suggested Citation
Sandra Misale & Rona Yaeger & Sebastijan Hobor & Elisa Scala & Manickam Janakiraman & David Liska & Emanuele Valtorta & Roberta Schiavo & Michela Buscarino & Giulia Siravegna & Katia Bencardino & Andr, 2012.
"Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer,"
Nature, Nature, vol. 486(7404), pages 532-536, June.
Handle:
RePEc:nat:nature:v:486:y:2012:i:7404:d:10.1038_nature11156
DOI: 10.1038/nature11156
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Dustin J. Flanagan & Raheleh Amirkhah & David F. Vincent & Nuray Gunduz & Pauline Gentaz & Patrizia Cammareri & Aoife J. McCooey & Amy M. B. McCorry & Natalie C. Fisher & Hayley L. Davis & Rachel A. R, 2022.
"Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Radia M. Johnson & Xueping Qu & Chu-Fang Lin & Ling-Yuh Huw & Avinashnarayan Venkatanarayan & Ethan Sokol & Fang-Shu Ou & Nnamdi Ihuegbu & Oliver A. Zill & Omar Kabbarah & Lisa Wang & Richard Bourgon , 2022.
"ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer,"
Nature Communications, Nature, vol. 13(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:486:y:2012:i:7404:d:10.1038_nature11156. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.